Safety and Efficacy of Denosumab vs Risedronate in Patients with Glucocorticoid-Induced Osteoporosis and Rheumatoid Arthritis

被引：0
|
作者：
Adachi, Jonathan [1 ]
Chines, Arkadi [2 ]
Huang, Shuang [2 ]
Saag, Kenneth [3 ]
Lems, Willem [4 ]
Geusens, Piet [5 ]
机构：
[1] McMaster Univ, St Josephs Healthcare, Hamilton, ON, Canada
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
[3] Univ Alabama Birmingham, Birmingham, AL USA
[4] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[5] Maastricht Univ, Genk, Belgium
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0445
引用
收藏
页码：916 / 919
页数：4
相关论文
共 50 条
  • [31] COMPARISON BETWEEN THE AMERICAN RECOMMENDATIONS AND THE JAPANESE GUIDELINES FOR GLUCOCORTICOID-INDUCED OSTEOPOROSIS IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS
    Furuya, T.
    Momohara, S.
    Taniguchi, A.
    Yamanaka, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 358 - 359
  • [32] Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis - Rates and predictors of care in an academic rheumatology practice
    Solomon, DH
    Katz, JN
    Jacobs, JP
    La Tourette, AM
    Coblyn, J
    ARTHRITIS AND RHEUMATISM, 2002, 46 (12): : 3136 - 3142
  • [33] Comparison Between the American Recommendations and the Japanese Guidelines for Glucocorticoid-Induced Osteoporosis in Japanese Patients with Rheumatoid Arthritis
    Furuya, Takefumi
    Momohara, Shigeki
    Taniguchi, Atsuo
    Yamanaka, Hisashi
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [34] Effects of denosumab versus teriparatide in glucocorticoid-induced osteoporosis patients with prior bisphosphonate treatment
    Hirooka, Yasuaki
    Nozaki, Yuji
    Inoue, Asuka
    Li, Jinhai
    Shiga, Toshihiko
    Kishimoto, Kazuya
    Sugiyama, Masafumi
    Kinoshita, Koji
    Funauchi, Masanori
    Matsumura, Itaru
    BONE REPORTS, 2020, 13
  • [35] The Efficacy of Minodronate in the Treatment of Glucocorticoid-induced Osteoporosis
    Hasegawa, Eriko
    Ito, Satoshi
    Takai, Chinatsu
    Kobayashi, Daisuke
    Nomura, Yumi
    Otani, Hiroshi
    Abe, Asami
    Ishikawa, Hajime
    Murasawa, Akira
    Narita, Ichiei
    Nakazono, Kiyoshi
    INTERNAL MEDICINE, 2018, 57 (15) : 2169 - 2178
  • [36] Bisphosphonates and glucocorticoid-induced osteoporosis: Efficacy and tolerability
    Lespessailles, Eric
    JOINT BONE SPINE, 2013, 80 (03) : 258 - 264
  • [37] Comparable efficacy of denosumab and romosozumab in patients with rheumatoid arthritis receiving glucocorticoid administration
    Kobayakawa, Tomonori
    Miyazaki, Akiko
    Kanayama, Yasuhide
    Hirano, Yuji
    Takahashi, Jun
    Suzuki, Takako
    Nakamura, Yukio
    MODERN RHEUMATOLOGY, 2023, 33 (01) : 96 - 103
  • [38] Glucocorticoid-induced osteoporosis in patients with sarcoidosis
    Adler, RA
    Funkhouser, HL
    Petkov, VI
    Berger, MM
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2003, 325 (01): : 1 - 6
  • [39] TREATMENT WITH DENOSUMAB IN GLUCOCORTICOSTEROID-INDUCED OSTEOPOROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Osipyan, M.
    Efraimidou, M.
    Bazeyan, S.
    Antikyan, A.
    Vardanyan, V.
    Ginosyan, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1752 - 1753
  • [40] Treatment of glucocorticoid-induced osteoporosis with concurrent denosumab and romosozumab: a case report
    Zhao, Alice S.
    Liu, Yi
    Mulvey, Joseph J.
    Tchang, Beverly G.
    OSTEOPOROSIS INTERNATIONAL, 2024, 35 (11) : 2061 - 2068
12345